TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Idexx Laboratories Norge AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
15,261
|
13,896
|
12,355 |
| Financial expenses |
12
|
8
|
0 |
| Earnings before taxes |
3,735
|
2,755
|
2,335 |
| Total assets |
38,772
|
30,857
|
26,314 |
| Current assets |
37,757
|
30,502
|
25,837 |
| Current liabilities |
20,895
|
15,552
|
12,149 |
| Equity capital |
17,276
|
14,632
|
13,385 |
| - share capital |
116
|
118
|
127 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
44.6%
|
47.4%
|
50.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
24.5%
|
19.8%
|
18.9% |
| Return on assets (ROA) |
9.7%
|
9.0%
|
8.9% |
| Current ratio |
180.7%
|
196.1%
|
212.7% |
| Return on equity (ROE) |
21.6%
|
18.8%
|
17.4% |
| Change turnover |
1,612
|
2,359
|
-96,056 |
| Change turnover % |
12%
|
20%
|
-89% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.